Detalhe da pesquisa
1.
Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice.
Pharmaceutics
; 15(7)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37514034
2.
Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
Pharm Dev Technol
; 14(4): 358-68, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19552563
3.
Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination.
Acta Pharm Sin B
; 9(6): 1231-1240, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31867168
4.
Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery.
Eur J Pharm Biopharm
; 68(2): 191-200, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17576056
5.
Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
Eur J Pharm Biopharm
; 70(1): 389-401, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18534833
6.
The therapeutic index of locally acting inhaled drugs as a function of their fine particle mass and particle size distribution: a literature review.
Curr Drug Deliv
; 5(2): 142-7, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18393817
7.
Prerequisites for a dry powder inhaler for children with cystic fibrosis.
PLoS One
; 12(8): e0183130, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28800360
8.
Targeting the small airways with dry powder adenosine: a challenging concept.
Eur Clin Respir J
; 4(1): 1369328, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29057065
9.
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
Eur J Pharm Sci
; 28(3): 171-8, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16650739
10.
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.
PLoS One
; 11(3): e0149768, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26959239
11.
Trends in the technology-driven development of new inhalation devices.
Drug Discov Today Technol
; 2(1): 47-57, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-24981755
12.
The role of disposable inhalers in pulmonary drug delivery.
Expert Opin Drug Deliv
; 12(1): 143-57, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25374325
13.
Can 'extrafine' dry powder aerosols improve lung deposition?
Eur J Pharm Biopharm
; 96: 143-51, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26220014
14.
A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods.
Eur J Pharm Biopharm
; 97(Pt A): 22-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26453913
15.
The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix.
Eur J Pharm Sci
; 23(2): 139-49, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15451002
16.
The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate.
Int J Pharm
; 465(1-2): 165-8, 2014 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24548720
17.
A proposed definition of the 'activity' of surface sites on lactose carriers for dry powder inhalation.
Eur J Pharm Sci
; 56: 102-4, 2014 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24613490
18.
The clinical relevance of dry powder inhaler performance for drug delivery.
Respir Med
; 108(8): 1195-203, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24929253
19.
Adenosine dry powder inhalation for bronchial challenge testing, part 1: inhaler and formulation development and in vitro performance testing.
Eur J Pharm Biopharm
; 86(1): 105-14, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24140941
20.
Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjects.
Eur J Pharm Biopharm
; 88(1): 148-52, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24780441